Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

71.27
Delayed Data
As of 3:59pm ET
 -0.41 / -0.57%
Today’s Change
35.37
Today|||52-Week Range
106.95
+10.98%
Year-to-Date
'Mad Money' Lightning Round: Buy, Buy, Buy Advanced Micro Devices
Sep 24 / TheStreet.com - Paid Partner Content
Why Cirrus Logic, bluebird bio, and GoPro Jumped Today
Sep 15 / MotleyFool.com - Paid Partner Content
bluebird bio (BLUE) in Focus: Stock Moves 11.4% Higher
Sep 16 / Zacks.com - Paid Partner Content
Why bluebird bio Inc. Jumped Again Today
Sep 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close71.68
Today’s open71.04
Day’s range70.14 - 71.78
Volume936,076
Average volume (3 months)1,023,080
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-162.84%
Earnings growth (this year)-31.91%
Earnings growth (next 5 years)-23.75%
Revenue growth (last year)-44.62%
P/E ratioNM
Price/Sales158.14
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+0.41+0.75%
ARIAARIAD Pharmaceutical...+0.44+3.25%
NKTRNektar Therapeutics-0.72-3.84%
RDUSRadius Health Inc-0.44-0.78%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$1.58
Annual revenue (last year)$14.1M
Annual profit (last year)-$166.8M
Net profit margin-1,184.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Financial &
Strategy Officer
Jeffrey T. Walsh
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs